Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļELV
āļāļ·āđāļāļāļĢāļīāļĐāļąāļElevance Health Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļOct 30, 2001
āļāļĩāļāļĩāđāļBoudreaux (Gail K)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ103158
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļOct 30
āļāļĩāđāļāļĒāļđāđ220 Virginia Avenue
āđāļĄāļ·āļāļINDIANAPOLIS
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ46204
āđāļāļĢāļĻāļąāļāļāđ18003311476
āđāļ§āđāļāđāļāļāđhttps://www.elevancehealth.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļELV
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļOct 30, 2001
āļāļĩāļāļĩāđāļBoudreaux (Gail K)
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
Mr. Antonio F. Neri
Independent Director
Dr. Bahija Jallal, Ph.D.
Independent Director
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
Ms. Deanna D. Strable-soethout
Ms. Deanna D. Strable-soethout
Independent Director
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Independent Director
Mr. Robert L. Dixon, Jr.
Independent Director
Mr. Mark B. Kaye
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
Mr. Ratnakar V. Lavu
Executive Vice President and Chief Digital Information Officer
Executive Vice President and Chief Digital Information Officer
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
Mr. Antonio F. Neri
Independent Director
Dr. Bahija Jallal, Ph.D.
Independent Director
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
Ms. Deanna D. Strable-soethout
Ms. Deanna D. Strable-soethout
Independent Director
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Independent Director
iShares U.S. Healthcare Providers ETF
Monarch Dividend Plus Index ETF
John Hancock Fundamental All Cap Core ETF
VictoryShares Free Cash Flow ETF
Bushido Capital US Equity ETF
State Street SPDR S&P Health Care Services ETF
First Eagle Global Equity ETF
First Trust Total US Market AlphaDEX ETF
First Trust Health Care Alphadex Fund
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
iShares U.S. Healthcare Providers ETF
āļŠāļąāļāļŠāđāļ§āļ4.43%
Monarch Dividend Plus Index ETF
āļŠāļąāļāļŠāđāļ§āļ3.25%
John Hancock Fundamental All Cap Core ETF
āļŠāļąāļāļŠāđāļ§āļ2.45%
GMO US Quality ETF
āļŠāļąāļāļŠāđāļ§āļ2.35%
VictoryShares Free Cash Flow ETF
āļŠāļąāļāļŠāđāļ§āļ2.32%
Bushido Capital US Equity ETF
āļŠāļąāļāļŠāđāļ§āļ2.2%
State Street SPDR S&P Health Care Services ETF
āļŠāļąāļāļŠāđāļ§āļ2.11%
First Eagle Global Equity ETF
āļŠāļąāļāļŠāđāļ§āļ2.03%
First Trust Total US Market AlphaDEX ETF
āļŠāļąāļāļŠāđāļ§āļ1.75%
First Trust Health Care Alphadex Fund
āļŠāļąāļāļŠāđāļ§āļ1.71%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
6.19B
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
ELV.NB Final Cash Dividend of gross USD 1.71 paid on Dec 19, 2025 going ex on Dec 05, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Sep 25, 2025 going ex on Sep 10, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Jun 25, 2025 going ex on Jun 10, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025
ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024
ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Sep 22, 2023 going ex on Sep 07, 2023
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ